Related Experiment Videos
Leishmaniasis vaccination: targeting the source of infection
The Journal of Experimental Medicine
|August 8, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.
Scandinavian journal of immunology·2017
Leishmania vaccine development: exploiting the host-vector-parasite interface.
Expert review of vaccines·2015
Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2013
Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
PML-driven sumoylation of PML::RARA-bound repressors drives hematopoietic progenitor immortalization.
The Journal of experimental medicine·2026
Borrelia burgdorferi disrupts gut barrier functions and microbiota-antibody interactions.
The Journal of experimental medicine·2026
Tumor-reactive LAG3+CD8+ T cells diverge into terminally exhausted cells and long-lived memory T cells.
The Journal of experimental medicine·2026
Molecular memory of cell fate: A missing dimension of neural implant biocompatibility.
The Journal of experimental medicine·2026
CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity.
The Journal of experimental medicine·2026
Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.
The Journal of experimental medicine·2026
Albumin and the kidney, a friend or foe.
Current opinion in critical care·2026
MiR-122 regulates liver tolerance.
JHEP reports : innovation in hepatology·2026